Author: Nathan Bissitt

Britain’s biggest coffee shop chain Costa has blamed a drop in sales on the woes affecting the British high street. Owner Whitbread said like-for-like sales fell by 2% in the first quarter, “principally from footfall weakness in traditional shopping

Read More

By Mark Kleinman. City editorA Cheltenham Gold Cup-winning jockey is about to toast a payday from the sale of his chain of dental practices that will catapult him into the ranks of Britain’s super-rich. Sky News has learnt that Sam Waley-Cohen, the founder of

Read More

Theresa May cannot have relished the prospect of speaking to a select gathering of the country’s foremost business leaders today. Airbus, one of the UK’s leading manufacturing employers, has just mused openly about the possibility of removing jobs from the

Read More

Uber has been granted a 15-month licence to operate in London in a decision which reverses a block placed on its service last year. Transport for London (TfL) refused to give the Uber a five-year operating licence last September, blaming failings in its approach to

Read More

Sir Elton John’s former manager will this week launch a second attempt to list a music royalties fund on the London Stock Exchange with one of the largest public market fundraisings so far this year. Sky News has learnt that Hipgnosis Songs, which was set up by the

Read More

The chief executive of British Airways’ parent company has called the £14bn cost to build Heathrow’s third runway “perverse” and cast doubt on the airport’s ability to deliver the project. Speaking to Sky News after MPs overwhelmingly

Read More

Britain’s car manufacturers have urged Prime Minister Theresa May to rethink her position on the customs union as investment in the country’s motor industry halves.  The Society of Motor Manufacturers and Traders (SMMT) said investment in new cars and

Read More

Carpetright has posted a full-year loss warning some suppliers withdrew stock as it went through a “difficult” trading period. The company said it made a loss of £70.5m for its financial year to 28 April 2018 compared with a profit of £900,000 in the same

Read More

The US drug regulator has approved the first cannabis-based epilepsy treatment for children as young as two. Nasdaq-listed GW Pharmaceuticals, which grows its own marijuana plants in glass houses in Britain, hopes the drug will be approved in the UK next year. The

Read More